ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Imi International Medical Innovations

Imi International Medical Innovations (IME)

0.00
0.00
(0.00%)
Closed April 18 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
-
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
-
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

IME Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

IME - Frequently Asked Questions (FAQ)

What is the current Imi Medical Innovations share price?
The current share price of Imi Medical Innovations is US$ 0.00
What is the 1 year trading range for Imi Medical Innovations share price?
Imi Medical Innovations has traded in the range of US$ 0.00 to US$ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BTTRBetter Choice Company Inc
US$ 2.025
(46.20%)
315.77k
CHROChannel Therapeutics Corporation
US$ 1.76
(40.24%)
39.58M
LLYXDefiance Daily Target 2X Long LLY ETF
US$ 19.57
(28.50%)
881.26k
DJTUT REX 2X Long DJT Daily Target ETF
US$ 19.17
(24.36%)
85.52k
MSOXAdvisorShares MSOS Daily Leveraged ETF
US$ 3.65
(19.67%)
663.15k
FOXOFOXO Technologies Inc
US$ 0.0841
(-22.84%)
1.65M
NVOXDefiance Daily Target 2x Long Nvo ETF
US$ 4.82
(-15.69%)
282.82k
AZTRAzitra Inc
US$ 0.28
(-11.95%)
381.57k
PTNPalatin Technologies Inc New
US$ 0.217001
(-11.79%)
13.13M
TOPPToppoint Holdings Inc
US$ 1.08
(-11.48%)
6.36k
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 9.20
(-1.50%)
233.66M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 7.7151
(-0.06%)
83.19M
TSLZT Rex 2X Inverse Tesla Daily Target ETF
US$ 3.66
(0.14%)
78.84M
SPYSPDR S&P 500
US$ 526.41
(0.14%)
78.53M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3.57
(6.09%)
69.9M

Discussion

View Full Feed
MasterBlastr MasterBlastr 3 minutes ago
Matt you probably got your girlfriend, your boss, your ex, and even your cat into this and nobody is talking to you anymore, right?
SVTE
mdotfdot mdotfdot 5 minutes ago
I wish I had paid attention. My friend mentioned it to me. What made you get in? I don't think it's over. 
HTZ
DTGoody DTGoody 5 minutes ago
What does this mean? Is there some really happening here? Please 🙏 let something positive happen for us shareholders!
BDEZ BDEZ 6 minutes ago
Too many on the dole to turn it around....
WhenMoon WhenMoon 6 minutes ago
My take on estimating the value of the Dexcel deal to Elite.
https://www.dexcel.com/dexcel-israel
This says Dexcel supplies about 20% of Israel's prescription drugs.
The ADHD market in Israel is 150 million according to that article someone posted. So take whatever percentage of
ELTP
BDEZ BDEZ 7 minutes ago
Powell is still in...WHY???????????
Mr. C Mr. C 7 minutes ago
They did this with a bunch of other companies in the past few months (See links).

I’m not looking too deep into this with the acquisition.

The timing and transfer of clients/business doesn’t have to happen immediately after a sale closing.

My understand
TGLO
Krombacher Krombacher 7 minutes ago
2can$,
You’re absolutely right—a short squeeze could thrust DBMM into the media spotlight, and that attention can be more than just fleeting hype. It can actually drive real business growth.

George Soros had a theory called reflexivity, where market perception can influence fun
DBMM
tdbowieknife tdbowieknife 8 minutes ago
Seems you're spinning out...

Good luck with all that BS.

.


Watch your wallet


Buyer Beware
Pump and Dump
http://images.investorshub.advfn.com/images/uploads/2013/12/13/fowqcCaveat_Emptor_5.JPG
HMBL
BDEZ BDEZ 8 minutes ago
63% of the population receives freebies
MasterBlastr MasterBlastr 8 minutes ago
Exactly. The stock isn't even associated with Delta Stag anymore. Its just a stock ticker, floating in space. The SEC will clean it up one of these days.
SVTE
BDEZ BDEZ 9 minutes ago
Convention Of States
BDEZ BDEZ 9 minutes ago
Texit
BDEZ BDEZ 9 minutes ago
Red State Secession
BDEZ BDEZ 9 minutes ago
IL & New England states are not turning around as well, it's over for them.
tdbowieknife tdbowieknife 10 minutes ago
So, they need to dump a shitload of stock first... Got it.

Lol...

They can't do an RS without first removing debt as well as preferred shares from short term lenders/investors. Suggesting that the company can't get finra to process an RS is basher fantasy

HMBL
tdbowieknife tdbowieknife 10 minutes ago
Wow... This just keeps getting better and better!!
It is a change in the share structure, but it isn't a new share structure. Not playing word games. The CEO said that they will address the SS later on. He wasn't referring to an increase in the AS, but rater getting the OS to a realistic numb
HMBL
arizona1 arizona1 11 minutes ago
https://bsky.app/profile/mrsbettybowers.bsky.social/post/3ln4lpszlns2z
Investor2014 Investor2014 11 minutes ago
All the more reason to demonstrate which effect contribution A2-73 vs. Donepezil has overtime during the trial and show it nicely in a chart.

Seems by implication of your post that you disagree with PW’s contention.
AVXL
Ayock Ayock 11 minutes ago
It's here!

https://scontent-sea1-1.xx.fbcdn.net/v/t39.30808-6/491543471_3495142853953655_8073568721757488411_n.jpg?_nc_cat=106&ccb=1-7&_nc_sid=127cfc&_nc_ohc=ap6PcZhWcrgQ7kNvwGHi86X&_nc_oc=AdmdZrPTeUTlbeENgbDOUS7_cgqCkVpOnNSMYjYKGToV9q7wwTC6aANJ6AeGGISyarc&_nc_zt=23&_nc_ht=scontent-se
kabunushi kabunushi 12 minutes ago
I'm curious: where did you get your figure for " 65+% of the volume yesterday was you guessed it, shares sold short."? If it were, how would they not would have swamped, the buyers?

FWIW, OBV shows +3M shares traded at the ask vs at the bid. A heavy imbalance in favor of buyers is n
NWBO
georgejjl georgejjl 13 minutes ago
In pharmacology, full agonists elicit the maximal receptor response possible, while partial agonists produce a submaximal response, even at full receptor occupancy. Partial agonists can act as competitive antagonists in the presence of full agonists, reducing the overall response due to competition
AVXL
B402 B402 13 minutes ago
Thanks for playing zab
NoMoDo NoMoDo 14 minutes ago
It is a change in the share structure, but it isn't a new share structure. Not playing word games. The CEO said that they will address the SS later on. He wasn't referring to an increase in the AS, but rater getting the OS to a realistic number - my guess would be 400-700mil. I already suggested
HMBL